Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-20 16:18 |
6-K
|
English | ZIP • 55.1 KB | ||
| 2023-06-20 07:30 |
Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer In…
|
English | PDF • 144.8 KB | ||
| 2023-06-20 07:30 |
Communiqué de presse : Sanofi remporte l’arbitrage lié à Zantac initié par Boeh…
|
French | PDF • 172.4 KB | ||
| 2023-06-13 14:00 |
Press Release: Sanofi “all in” on artificial intelligence and data science to s…
|
English | PDF • 162.9 KB | ||
| 2023-06-13 14:00 |
Communiqué de presse : Sanofi mise sur l'intelligence artificielle et la scienc…
|
French | PDF • 165.9 KB | ||
| 2023-06-08 23:19 |
Press Release: FDA Advisory Committee unanimously recommends nirsevimab as firs…
|
English | PDF • 233.2 KB | ||
| 2023-06-08 23:19 |
Communiqué de presse : Le Comité consultatif de la FDA recommande le nirsevimab…
|
French | PDF • 247.8 KB | ||
| 2023-06-02 16:53 |
6-K
|
English | ZIP • 47.0 KB | ||
| 2023-06-01 07:30 |
Communiqué de presse : Sanofi lance son plan mondial 2023 d’actionnariat salarié
|
French | PDF • 150.3 KB | ||
| 2023-06-01 07:30 |
Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan
|
English | PDF • 150.3 KB | ||
| 2023-05-31 07:00 |
Press Release: Positive Phase 2 data of novel investigational anti-CD40L antibo…
|
English | PDF • 193.5 KB | ||
| 2023-05-31 07:00 |
Communiqué : Des données positives de phase II relatives au frexalimab, nouvel …
|
French | PDF • 190.4 KB | ||
| 2023-05-30 17:15 |
SD
|
English | ZIP • 12.1 KB | ||
| 2023-05-25 18:10 |
Press Release: Annual General Meeting of May 25, 2023 – Frédéric Oudéa new Chai…
|
English | PDF • 157.0 KB | ||
| 2023-05-25 18:10 |
Communiqué de presse : Assemblée Générale Annuelle du 25 mai 2023 – Frédéric Ou…
|
French | PDF • 149.5 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
